IBDEI04C ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5415,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5415,2)
 ;;=^334244
 ;;^UTILITY(U,$J,358.3,5416,0)
 ;;=466.0^^40^407^2
 ;;^UTILITY(U,$J,358.3,5416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5416,1,3,0)
 ;;=3^466.0
 ;;^UTILITY(U,$J,358.3,5416,1,4,0)
 ;;=4^BRONCHITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,5416,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,5417,0)
 ;;=682.8^^40^407^3
 ;;^UTILITY(U,$J,358.3,5417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5417,1,3,0)
 ;;=3^682.8
 ;;^UTILITY(U,$J,358.3,5417,1,4,0)
 ;;=4^CELLULITIS, SITE NEC
 ;;^UTILITY(U,$J,358.3,5417,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,5418,0)
 ;;=575.10^^40^407^4
 ;;^UTILITY(U,$J,358.3,5418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5418,1,3,0)
 ;;=3^575.10
 ;;^UTILITY(U,$J,358.3,5418,1,4,0)
 ;;=4^CHOLECYSTITIS,UNSP
 ;;^UTILITY(U,$J,358.3,5418,2)
 ;;=^23341
 ;;^UTILITY(U,$J,358.3,5419,0)
 ;;=372.39^^40^407^5
 ;;^UTILITY(U,$J,358.3,5419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5419,1,3,0)
 ;;=3^372.39
 ;;^UTILITY(U,$J,358.3,5419,1,4,0)
 ;;=4^CONJUNCTIVITIS NEC
 ;;^UTILITY(U,$J,358.3,5419,2)
 ;;=^87441
 ;;^UTILITY(U,$J,358.3,5420,0)
 ;;=110.1^^40^407^6
 ;;^UTILITY(U,$J,358.3,5420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5420,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,5420,1,4,0)
 ;;=4^DERMATOPHYTOSIS OF NAIL
 ;;^UTILITY(U,$J,358.3,5420,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,5421,0)
 ;;=562.11^^40^407^7
 ;;^UTILITY(U,$J,358.3,5421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5421,1,3,0)
 ;;=3^562.11
 ;;^UTILITY(U,$J,358.3,5421,1,4,0)
 ;;=4^DIVERTICULITIS
 ;;^UTILITY(U,$J,358.3,5421,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,5422,0)
 ;;=424.99^^40^407^8
 ;;^UTILITY(U,$J,358.3,5422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5422,1,3,0)
 ;;=3^424.99
 ;;^UTILITY(U,$J,358.3,5422,1,4,0)
 ;;=4^ENDOCARDITIS NEC
 ;;^UTILITY(U,$J,358.3,5422,2)
 ;;=^87573
 ;;^UTILITY(U,$J,358.3,5423,0)
 ;;=707.15^^40^407^9
 ;;^UTILITY(U,$J,358.3,5423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5423,1,3,0)
 ;;=3^707.15
 ;;^UTILITY(U,$J,358.3,5423,1,4,0)
 ;;=4^FOOT ULCER
 ;;^UTILITY(U,$J,358.3,5423,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,5424,0)
 ;;=558.9^^40^407^10
 ;;^UTILITY(U,$J,358.3,5424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5424,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,5424,1,4,0)
 ;;=4^GASTROENTERITIS
 ;;^UTILITY(U,$J,358.3,5424,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,5425,0)
 ;;=042.^^40^407^1
 ;;^UTILITY(U,$J,358.3,5425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5425,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,5425,1,4,0)
 ;;=4^AIDS (SYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5425,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,5426,0)
 ;;=V08.^^40^407^11
 ;;^UTILITY(U,$J,358.3,5426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5426,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,5426,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5426,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,5427,0)
 ;;=487.1^^40^407^12
 ;;^UTILITY(U,$J,358.3,5427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5427,1,3,0)
 ;;=3^487.1
 ;;^UTILITY(U,$J,358.3,5427,1,4,0)
 ;;=4^INFLUENZA
 ;;^UTILITY(U,$J,358.3,5427,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,5428,0)
 ;;=730.00^^40^407^13
 ;;^UTILITY(U,$J,358.3,5428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5428,1,3,0)
 ;;=3^730.00
 ;;^UTILITY(U,$J,358.3,5428,1,4,0)
 ;;=4^OSTEOMYELITIS
 ;;^UTILITY(U,$J,358.3,5428,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,5429,0)
 ;;=382.9^^40^407^14
 ;;^UTILITY(U,$J,358.3,5429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5429,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,5429,1,4,0)
 ;;=4^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,5429,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,5430,0)
 ;;=614.9^^40^407^15
 ;;^UTILITY(U,$J,358.3,5430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5430,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,5430,1,4,0)
 ;;=4^PELVIC INFLAMMATORY DISEASE
 ;;^UTILITY(U,$J,358.3,5430,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,5431,0)
 ;;=462.^^40^407^16
 ;;^UTILITY(U,$J,358.3,5431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5431,1,3,0)
 ;;=3^462.
 ;;^UTILITY(U,$J,358.3,5431,1,4,0)
 ;;=4^PHARYNGITIS
 ;;^UTILITY(U,$J,358.3,5431,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,5432,0)
 ;;=486.^^40^407^17
 ;;^UTILITY(U,$J,358.3,5432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5432,1,3,0)
 ;;=3^486.
 ;;^UTILITY(U,$J,358.3,5432,1,4,0)
 ;;=4^PNEUMONIA
 ;;^UTILITY(U,$J,358.3,5432,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,5433,0)
 ;;=590.80^^40^407^18
 ;;^UTILITY(U,$J,358.3,5433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5433,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,5433,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,5433,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,5434,0)
 ;;=711.00^^40^407^19
 ;;^UTILITY(U,$J,358.3,5434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5434,1,3,0)
 ;;=3^711.00
 ;;^UTILITY(U,$J,358.3,5434,1,4,0)
 ;;=4^SEPTIC JOINT
 ;;^UTILITY(U,$J,358.3,5434,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,5435,0)
 ;;=461.8^^40^407^20
 ;;^UTILITY(U,$J,358.3,5435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5435,1,3,0)
 ;;=3^461.8
 ;;^UTILITY(U,$J,358.3,5435,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,5435,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,5436,0)
 ;;=473.8^^40^407^21
 ;;^UTILITY(U,$J,358.3,5436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5436,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,5436,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,5436,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,5437,0)
 ;;=463.^^40^407^22
 ;;^UTILITY(U,$J,358.3,5437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5437,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,5437,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,5437,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,5438,0)
 ;;=011.90^^40^407^23
 ;;^UTILITY(U,$J,358.3,5438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5438,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,5438,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,5438,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,5439,0)
 ;;=465.9^^40^407^24
 ;;^UTILITY(U,$J,358.3,5439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5439,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,5439,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,5439,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,5440,0)
 ;;=599.0^^40^407^25
 ;;^UTILITY(U,$J,358.3,5440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5440,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,5440,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,5440,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,5441,0)
 ;;=616.10^^40^407^26
 ;;^UTILITY(U,$J,358.3,5441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5441,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,5441,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,5441,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,5442,0)
 ;;=277.30^^40^408^1
 ;;^UTILITY(U,$J,358.3,5442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5442,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,5442,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,5442,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,5443,0)
 ;;=277.31^^40^408^3
 ;;^UTILITY(U,$J,358.3,5443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5443,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,5443,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,5443,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,5444,0)
 ;;=277.39^^40^408^2
 ;;^UTILITY(U,$J,358.3,5444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5444,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,5444,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,5444,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,5445,0)
 ;;=446.21^^40^408^4
 ;;^UTILITY(U,$J,358.3,5445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5445,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,5445,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,5445,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,5446,0)
 ;;=580.0^^40^408^8
 ;;^UTILITY(U,$J,358.3,5446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5446,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,5446,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,5446,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,5447,0)
 ;;=580.4^^40^408^9
 ;;^UTILITY(U,$J,358.3,5447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5447,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,5447,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
 ;;^UTILITY(U,$J,358.3,5447,2)
 ;;=^270339
 ;;^UTILITY(U,$J,358.3,5448,0)
 ;;=580.9^^40^408^7
 ;;^UTILITY(U,$J,358.3,5448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5448,1,3,0)
 ;;=3^580.9
 ;;^UTILITY(U,$J,358.3,5448,1,4,0)
 ;;=4^NEPHRITIS,AC NOS
 ;;^UTILITY(U,$J,358.3,5448,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,5449,0)
 ;;=582.0^^40^408^14
 ;;^UTILITY(U,$J,358.3,5449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5449,1,3,0)
 ;;=3^582.0
 ;;^UTILITY(U,$J,358.3,5449,1,4,0)
 ;;=4^NEPHRITIS,CHR PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,5449,2)
 ;;=^270347
 ;;^UTILITY(U,$J,358.3,5450,0)
 ;;=582.1^^40^408^12
 ;;^UTILITY(U,$J,358.3,5450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5450,1,3,0)
 ;;=3^582.1
 ;;^UTILITY(U,$J,358.3,5450,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOUS
 ;;^UTILITY(U,$J,358.3,5450,2)
 ;;=^24388
 ;;^UTILITY(U,$J,358.3,5451,0)
 ;;=582.2^^40^408^11
 ;;^UTILITY(U,$J,358.3,5451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5451,1,3,0)
 ;;=3^582.2
 ;;^UTILITY(U,$J,358.3,5451,1,4,0)
 ;;=4^NEPHRITIS,CHR MEMBRANOPROLIF
 ;;^UTILITY(U,$J,358.3,5451,2)
 ;;=^24386
 ;;^UTILITY(U,$J,358.3,5452,0)
 ;;=582.4^^40^408^15
 ;;^UTILITY(U,$J,358.3,5452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5452,1,3,0)
 ;;=3^582.4
 ;;^UTILITY(U,$J,358.3,5452,1,4,0)
 ;;=4^NEPHRITIS,CHR RAPID PROGR
 ;;^UTILITY(U,$J,358.3,5452,2)
 ;;=^270348
 ;;^UTILITY(U,$J,358.3,5453,0)
 ;;=582.81^^40^408^10
 ;;^UTILITY(U,$J,358.3,5453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5453,1,3,0)
 ;;=3^582.81
 ;;^UTILITY(U,$J,358.3,5453,1,4,0)
 ;;=4^NEPHRITIS,CHR IN OTH DIS
 ;;^UTILITY(U,$J,358.3,5453,2)
 ;;=^270350
 ;;^UTILITY(U,$J,358.3,5454,0)
 ;;=582.9^^40^408^13
 ;;^UTILITY(U,$J,358.3,5454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5454,1,3,0)
 ;;=3^582.9
